I am in charge of eMyosound's clinical development program, HTA, HEOR and market access.

Head of Clinical epidemiological, HTA and HEOR services to Pharma, MedTech, IVD, biotech

Assignments in the fields of MedTechn pharma, BioTech and iVD:- Organize and conduct all aspects of epidemiological surveys, clinical trials & HEO studies.- Clinical data and statistical analyses (STATA, R, Matlab, Maple).- Study budget management.- Investigator recruitement, training and supervision. - Monitor recruitement, training and supervision. - GCP and regulatory compliance audits.- Set up GCP compliance plan and manage CRAs- Participation in scientific committees and clinical event review committees- Data analysis and study reports.- Protocol and study master file approvals.- Health economic sub-study planning, follow-up and analysis..- Prepare clinical reports for regulatory submissions & publication manuscripts.- Conduct meta-analyses (Revman, STATA)- Risk-efficacy, cost-utility decision model programming (TreeAge, Excel). Budget impact analysis. - Develop evidence-based, clinical decision algorithms for routine practice in Python and Java.- Conduct health technology assessments and formulate value propositions for products in line with clinical evidence and epidemiology.- Health technology assessment strategy development and evidence compilation for practice guideline and reimbursement applications.

Part time staff physician & clinical investigator. My main field were 1) Acute coronary syndrome ; 2) Surgical infections ; 3) type I diabetes care: CGMs, insulin pumps, closed-loop systems ; type II DM drug treatments, 4) Thyroid cancer management with trials assessing the impact of reducing radioactive iodine exposure.

Consulting services in epidemiology, biostatistics, clinical trial design and analysis, HEOR, HTA. Clients: MedTech, IVD, biotech. Support to regulatory affairs.

In charge of populational cohort and clinical pathway study of patients with heart failure. Analysis of cardiac assist surgery cohort analysis and study report. Comparison of clinical outcomes with populational cohort.

1) Infantry unit physician, 2) Staff epidemiologist & biostatistician.

St Perine Hospital: Pharmaco-epidemiological longitudinal observational cohort study: Incidence of stroke/TIA in elderly according to plasma lipid profile and hemorheology. Statistical analysis of interaction between pentoxifylline intake, polyunsaturated fatty acid food supplement and confounders. Supervisors: Philippe Darcey, MD and Fathi Driss, DPharm.